Journal of Pediatric Health Care
Volume 23, Issue 2 , Pages 101-108 , March 2009

Respiratory Syncytial Virus: From Primary Care to Critical Care

  • Lauren R. Sorce, RN, MSN, CCRN, CPNP-AC/PC, FCCM

      Affiliations

    • Corresponding Author InformationCorrespondence: Lauren R. Sorce, RN, MSN, CCRN, CPNP-AC/PC, FCCM, 2300 Children's Plaza, Box 246, Chicago, IL 60614.

References 

  1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn . Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics. 1998;102:1211–1216
  2. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn . Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442–1446
  3. Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. [Electronic version] The Pediatric Infectious Disease Journal. 1998;17:231–236
  4. Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteremia and antibiotic use in respiratory syncytial virus infections. [Electronic version] Archives of Disease in Childhood. 2004;49:363–367
  5. Castro-Rodriguez JA, Holberg CJ, Morgan WJ, Wright AL, Halonen M, Taussig LM, et al. Relation of two different subtypes of croup before age three to wheezing, atopy and pulmonary function during childhood: A prospective study. [Electronic version] Pediatrics. 2001;107:512–518
  6. Chanock RM, Roizman B, Meyers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent. Part I: Isolation, properties and characterization. American Journal of Hygiene. 1957;66:281–290
  7. Checchia PA, Appel HJ, Kahn S, Smith FA, Shulman ST, Pahl E, et al. Myocardial injury in children with respiratory syncytial virus infection. [Electronic version] Pediatric Critical Care Medicine. 2000;1:146–150
  8. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta analysis. Pediatric Critical Care Medicine. 2004;5:482–489
  9. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. [Electronic version] Journal of Infectious Diseases. 2005;191:1861–1868
  10. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. [Electronic version] Archives of Disease in Childhood. 2004;89:1155–1157
  11. Eisenhut M, Sidaras D, Johnson R, Newland P, Thorburn K. Cardiac troponin T levels and myocardial involvement in children with severe respiratory syncytial virus lung disease. Acta Paediatrica. 2004;83:887–890
  12. Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH, et al. Cardiac Synagis Study Group Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. Journal of Pediatrics. 2003;143:532–540
  13. Figueras-Aloy J, Carbonell-Estrany X, Quero J IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestation age of 33-35 weeks in Spain. The Pediatric Infectious Disease Journal. 2004;23:815–820
  14. Gilca R, Serres GD, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. Journal of Infectious Diseases. 2006;293:54–58
  15. Goldrick RA. Respiratory syncytial virus. American Journal of Nursing. 2004;104:54–56
  16. Henrickson KJ. Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatric Annals. 2005;34:24–31
  17. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infant in the United States. The Pediatric Infectious Disease Journal. 2003;22:483–489
  18. Howard TS, Hoffman LH, Stang PE, Simoes EAF. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges and mortality. [Electronic version] The Journal of Pediatrics. 2000;137:227–232
  19. IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. [Electronic version] Pediatrics. 1998;102:531–537
  20. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. [Electronic version] Journal of Infectious Diseases. 2004;189:1856–1865
  21. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilators for bronchiolitis. [Electronic version] The Cochrane Database of Systematic Reviews; 2. 2006;
  22. Kim HW, Canchola JG, Brandt BD, Pyles G, Chanock RM, Jensen K, et al. Respiratory syncytial virus in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology. 1969;89:422–434
  23. King VJ, Viswanathan M, Bordley C, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children a systematic review. [Electronic version] Archives of Pediatric and Adolescent Medicine. 2004;158:127–137
  24. Kneyber MCJ, van Oud-Alblas HB, van Vliet M, Uiterwaal CSPM, Kimpen JLL, van Vught AJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory track disease. [Electronic version] Intensive Care Medicine. 2005;31:680–685
  25. Law BJ, Langley JM, Allen U, Paes B, Lee DSC, Mitchell I, et al. The pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. The Pediatric Infectious Disease Journal. 2004;23:806–814
  26. LeSaux N, Gaboury I, MacDonald N. Maternal respiratory syncytial virus antibody titers: season and children matter. The Pediatric Infectious Disease Journal. 2003;22:563–564
  27. Levine DA, Platt SK, Dayan PS, Macias CG, Zorc JJ, Krief W, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. [Electronic version] Pediatrics. 2004;116:1728–1734
  28. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with vial bronchiolitis. [Electronic version] Chest. 2003;123:481–487
  29. Martinello RA, Chen MD, Weibel C, Kahn JS. Correlation between respiratory syncytial virus genotype and severity of illness. The Journal of Infectious Diseases. 2002;186:839–842
  30. Mejais A, Chavez-Bueno S, Rios AM, Aten MF, Raynor B, Peromingo E, et al. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrobial Agents and Chemotherapy. 2005;49:4700–4707
  31. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. [Electronic version] The Pediatric Infectious Disease Journal. 2003;22:S40–S45
  32. Moynihan JA, Brown L, Sehra R, Checcia PA. Cardiac troponin I as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: A pilot study. [Electronic version] The American Journal of Emergency Medicine. 2003;21:479–482
  33. Moynihan JA, Kim TY, Young T, Checchia PA. Rate of palivizumab administration in accordance with current recommendations among hospitalized children. Journal of Pediatric Heath Care. 2004;18:224–227
  34. Openshaw PJM. Potential therapeutic implications of new insights into respiratory syncytial virus disease. [Electronic version] Respiratory Research. 2002;3:S15–S20
  35. Oray-Schrom P, Phoenix C, St. Martin D, Amoateng-Adjepong Y. Sepsis workup in febrile infants 0-90 days of age with respiratory syncytial virus infection. [Electronic version] Pediatric Emergency Care. 2003;195:314–319
  36. Panitch HB. Viral respiratory infection in children with technology dependence and neuromuscular disorders. [Electronic version] The Pediatric Infectious Disease Journal. 2004;23:S222–S227
  37. Prais D, Schonfeld T, Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. [Electronic version] Pediatrics. 2003;112:548–552
  38. Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. [Electronic version] The Pediatric Infectious Disease Journal. 2004;23:267–269
  39. Ramadan HH, Farr RW, Wetmore SJ. Adenovirus and respiratory syncytial virus in chronic sinusitis using polymerase chain reaction. [Electronic version] Laryngoscope. 1997;107:923–925
  40. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. [Electronic version] The Pediatric Infectious Disease Journal. 2004;23:990–994
  41. Roush, D. (2007). Respiratory syncytial virus (RSV). Retrieved February 13, 2008, from http://www.nlm.nih.gov/medlineplus/ency/article/001564.htm
  42. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. [Electronic version] Chest. 2002;233:2015–2020
  43. Sato M, Saito R, Takatsugu S, Sano Y, Nishikawa M, Sasaki A, et al. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. Journal of Clinical Microbiology. 2005;43:36–40
  44. Sheeran P, Hasan J, Carubelli C, Saavedra J, Johnson C, Krisher K, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. [Electronic version] The Pediatric Infectious Disease Journal. 1999;18:115–122
  45. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. American Journal of Respiratory and Critical Care Medicine. 2005;171:137–141
  46. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. The Journal of Pediatrics. 2003;143(5 Suppl.):S118–S126
  47. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. [Electronic version] Lancet. 1999;254:541–545
  48. Stensballe LG, Kristensen K, Simoes EAF, Jensen H, Nielsen J, Benn CS, et al. Atopic disposition, wheezing and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: A nested case-control study. [Electronic version] Pediatrics. 2006;118:1360–1368
  49. Tristram DA, Welliver RC. Respiratory syncytial virus. [Electronic version] In:  Long SS,  Pickering LK,  Probe CG editor. Long: Principles and practice of pediatric infectious diseases. 2nd ed.. New York: Elsevier; 2003;p. 1140–1149
  50. Venkatesh MP, Weisman LE. Prevention and treatment of respiratory syncytial virus infection in infants: An update. Expert Review of Vaccines. 2006;5:261–268
  51. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. The Journal of Pediatrics. 2003;143(5 Suppl.):S112–S117
  52. Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial viral pneumonia. The Pediatric Infectious Disease Journal. 2004;23:1065–1066

PII: S0891-5245(07)00460-9

doi: 10.1016/j.pedhc.2007.11.004

Journal of Pediatric Health Care
Volume 23, Issue 2 , Pages 101-108 , March 2009

Article Tools

* Image Usage & Resolution